2008
Regulation of Expression, Mode of Action and Downstream Targets of ORF50 Protein in KSHV Lytic Cycle Activation
Chang P, Ye J, Miller G. Regulation of Expression, Mode of Action and Downstream Targets of ORF50 Protein in KSHV Lytic Cycle Activation. 2008, 521-553. DOI: 10.1007/978-0-387-68945-6_21.Peer-Reviewed Original ResearchKaposi's sarcoma-associated herpesvirusSarcoma-associated herpesvirusLytic cycle activationMulticentric Castleman's diseaseHuman herpesvirus 8Primary effusion lymphomaHIV/AIDSORF50 proteinCastleman's diseaseViral lytic replication cycleLytic replication cycleKaposi's sarcomaHerpesvirus 8Viral life cycleEffusion lymphomaViral gene productsHuman malignanciesViral targetsKSHV pathogenesisLytic replicationMode of action
1991
How Zebra, A Weak Transactivator, Exerts Strong Biologic Effects
Miller G, Taylor N, Kolman J, Baumann R, Katz D, Himmelfarb H, Carey M, Ptashne M. How Zebra, A Weak Transactivator, Exerts Strong Biologic Effects. Experimental Biology And Medicine 1991, 27-42. DOI: 10.1007/978-1-4612-0405-3_4.Peer-Reviewed Original Research
1985
Antibody Responses to Two Epstein-Barr Virus Nuclear Antigens Defined by Gene Transfer
Miller G, Grogan E, Fischer D, Niederman J, Schooley R, Henle W, Lenoir G, Liu C. Antibody Responses to Two Epstein-Barr Virus Nuclear Antigens Defined by Gene Transfer. New England Journal Of Medicine 1985, 312: 750-755. PMID: 2983211, DOI: 10.1056/nejm198503213121204.Peer-Reviewed Original ResearchConceptsChronic active EBV infectionActive EBV infectionEBV infectionNuclear antigenEpstein-Barr virus nuclear antigenEpstein-Barr virus DNAEBV-seropositive subjectsAbnormal immune responseAssociation of EBVNorth African patientsAbsence of antibodiesSuch patientsAfrican patientsSerologic studiesImmune responseNasopharyngeal carcinomaLymphoid cellsPatientsViral gene productsSpecific viral gene productsViral mutationsSerologic reactionsAntigenSerum samplesM antigen